---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013731"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:32:03.672321+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Majority stockholder approves 5x increase in authorized Class A common shares to 2.5B

## Summary
- Majority stockholder (Rennova Health, controlled by CEO) holding 56.71% of voting rights approved share authorization increase.
- Authorized Class A Common Stock to rise from 500M to 2.5B shares, effective by March 31, 2026 at Board's discretion.
- The increase requires no further stockholder approval; definitive Information Statement to be mailed, effective 20 days after mailing.
- CEO Seamus Lagan controls the majority stockholder, giving him effective control over the authorization.

## SEC filing metadata
- accession: 0001493152-25-013731
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000149315225013731/0001493152-25-013731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000149315225013731/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013731
- JSON: https://secwatch.observer/filing/0001493152-25-013731.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013731.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.